Minnesota Legislature
HF 1183
Status in the House for the 92nd Legislature (2021 - 2022)
Revisor number: 21-02806
Description
Excessive drug price increases prohibited by manufacturers to generic or off-patent drugs, attorney general authorized to take action against manufacturers for price increases, withdrawal of generic or off-patent drug sales prohibited, and civil penalties imposed.
Authors
Actions
House
| 02/18/2021 |
Introduction and first reading, referred to Commerce Finance and Policy
|
| 02/25/2021 |
Committee report, to adopt as amended and re-refer to Health Finance and Policy
pg.
606a
|
| 02/25/2021 |
Author added Boe
pg.
655
|
| 03/04/2021 |
Committee report, to adopt as amended and re-refer to State Government Finance and Elections
pg.
771a
|
| 03/04/2021 |
Author added Bierman
pg.
823
|
| 03/08/2021 |
Author added Klevorn
pg.
891
|
| 03/11/2021 |
Committee report, to adopt and re-refer to Ways and Means
pg.
983
|
| 03/25/2021 |
Author added Greenman
pg.
1366
|
| 04/09/2021 |
Author stricken Boe
pg.
2068
|